Abundance of urea cycle enzymes in the liver is regulated by the dietary protein intake. Although urea cycle enzyme levels rise in response to a high protein diet, signaling networks that sense dietary protein intake and trigger changes in expression of urea cycle genes have not been identified. The aim of this study was to identify signaling pathway(s) that respond to changes in protein intake and regulate expression of urea cycle genes in mice and human hepatocytes. Mice were adapted to either control or high (HP) protein diets followed by isolation of liver protein and mRNA and integrated analysis of the proteomic and transcriptome profiles. HP diet led to increased expression of mRNA and enzymes in amino acid degradation pathways, and decreased expression of mRNA and enzymes in carbohydrate and fat metabolism, which implicated AMPK as a possible regulator. Primary human hepatocytes, treated with AICAR an activator of AMPK, were used to test whether AMPK regulates expression of urea cycle genes. The abundance of CPS1 and OTC mRNA increased in hepatocytes treated with AICAR, which supports a role for AMPK signaling in regulation of the urea cycle. Because AMPK is either a target of drugs used to treat type-2 diabetes, these drugs might increase the expression of urea cycle enzymes in patients with urea cycle disorders, which could be the basis of a new therapeutic approach.
and arginase 1 (ARG1, EC 3.5.3.1), and two transporters, ornithine/citrulline 5 transporter (ORNT) and aspartate/glutamate transporter (ARALAR2 or Citrin) 6 comprise the urea cycle in the liver [1, 2] . The physiological function of the urea cycle is 7 to convert ammonia, a neuro-toxic product of protein catabolism, into urea. Defects in 8 any of the urea cycle enzymes and transporters, collectively known as urea cycle 9 disorders (UCD), lead to hyperammonemia, which causes neuro-cognitive symptoms 10 such as nausea, lethargy, and seizures, and, in severe cases, coma and death [3] . Loss of 11 function of any of the urea cycle enzymes causes complete block of ureagenesis, which 12 frequently results in severe hyperammonemia within first few days of life [3, 4] . 13 Approximately 70% of patients with UCD have partial defects in urea cycle enzymes [4] 14 with decreased capacity to produce urea; they can develop hyperammonemia at any 15 time, usually due to infections, invasive medical procedures, fasting or lifestyle changes 16 that result in increased protein catabolism [5] [6] [7] [8] [9] [10] [11] . Low protein diet and activation of 17 alternative pathways for disposal of ammonia are standard therapies for urea cycle 18 disorders (UCD) aimed to reduce ammonia production and increase its elimination, 19 respectively [4, [12] [13] [14] . Decreased protein intake can be sensed by the body [15] , leading 20 to decreased expression of urea cycle genes and enzymes, including the defective one in 21 patients with partial UCD. This can further diminish patient's capacity to produce urea 22 and increases their risk of hyperammonemia upon sudden increase of protein catabolism. 23 However, this also presents an opportunity for development of new treatments for 24 partial UCD with drugs that increase the expression of urea cycle enzymes despite 25 patients' low protein diet. Development of such drugs requires detailed understanding of 26 the sensory mechanisms and signaling pathways that regulate expression of the urea 27 cycle genes and enzymes is response to dietary protein intake changes. 28 
29
Expression of urea cycle genes and abundance of urea cycle enzymes in the liver depend 30 on the rate of protein catabolism, which is determined by the dietary protein intake and 31 the rate of degradation of cellular proteins [15] [16] [17] [18] . Glucocorticoids and glucagon act via 32 glucocorticoid receptor and cAMP signaling to activate expression of urea cycle genes 33 [19] [20] [21] [22] [23] [24] [25] [26] while the role of insulin in the regulation of urea cycle is unclear [27] . 34 Glucocorticoid receptor regulates expression of the rat Cps1 gene [28] and cAMP 35 response element binding (CREB) transcription factor regulates rat Cps1 and human 36 NAGS genes [29] [30] [31] but transcription factors that regulate expression of each urea cycle 37 gene (Table 1) do not reveal a common regulatory mechanism that might be responsible 38 for coordinated changes in expression of all urea cycle genes in response to changes in The Institutional Animal Care and Use Committee of the Children's National Medical 48 Center approved all experimental procedures involving mice. 49 
50
Groups of eight syngeneic adult male C57BL/6 mice were randomly assigned and fed 51 isocaloric low (20% protein, LP) or high (60% protein, HP) protein diets on a fast/feast 52 cycle consisting of 8 hours fasting, with unlimited access to water, followed by 16 hours 53 ad libitum feeding for 11 days. On the 12 th day mice were sacrificed immediately before 54 scheduled food reintroduction (T0), and at 30 min. (T30), 60 min. (T60) and 120 min. 55 (T120) after reintroduction of food ( Figure S1 ). Eight mice were sacrificed at each time 56 point and livers were collected and immediately frozen in liquid nitrogen.
57
RNA sample preparation and microarray processing 58 Hierarchical Clustering Explorer (HCE) 3.5 power analysis tool [32] was used to 59 determine that three replicates would be sufficient to allow for detection of significant 60 differences in mRNA levels for 60-80% of probe sets present on each microarray. 61 
62
RNA was isolated from frozen liver using TRIzol reagent (Invitrogen). AMPKa, mTOR, 4E-BP1 and β-actin proteins (Cell Signaling Technologies) at a 1:1000 178 dilution. The membranes were washed three times for 10 min, each with TBS containing 179 0.1% Tween 20, followed by incubation with secondary antibody at a 1:10,000 dilution. 180 Image analyses were performed using an Odyssey Imager (LiCor, Lincoln, NE).
181
Primary hepatocyte culture
182
The Liver Tissue Cell Distribution System (LTCDS) is a National Institutes of Health 183 (NIH)-funded collaborative network to provide human liver tissue from regional centers 184 for distribution to scientific investigators. The regional centers have active liver pathologic liver for which the transplant is performed. Figure 1A ). Food intake was lower in mice fed the high protein diet ( Figure 1B) , most 212 likely due to the prolonged satiety following consumption of high protein food [38, 39] . 213 Mice fed high protein diet drank more water, presumably to allow for increased urea 214 excretion through urination ( Figure 1C ). While urea excretion was not measured, the 215 high protein diet would result in increased urea production [40] . 
Proteomic and transcriptional profiling 217
Livers were harvested from mice fed either HP or LP diet on a time-restricted feeding 218 schedule of 6 hr. fasting and 18 hr. feeding for 11 days. On the 12 th day, livers were 219 collected immediately prior to reintroduction of food, and 30, 60, and 120 minutes after 220 reintroduction of food (T0, T30, T60 and T120 time points, respectively); expression 221 microarrays were used to assess mRNA levels at each time point and spike-in differential 222 proteome profiling was used to detect changes in protein abundance in mice fed either 223 LP or HP diets.
Differences in expression levels of urea cycle mRNA and proteins were assessed first.
226
Expression levels of Cps1, Otc, Ass, and Asl mRNA were higher in mice fed HP diet,
227
while the abundance of the Nags and Arg1 mRNA did not change in response to diet
228
( Figures 2A and 2B ). The Cps1, Otc, Ass, Asl and Arg1 proteins were more abundant 229 in the livers of mice fed HP diet ( Figures 2C-2E ), similar to changes in their abundance 230 and enzymatic activity in response to HP diet previously observed [18, 41] . The Nags 231 protein was assayed only by immunoblotting because it could not be detected by mass 232 spectroscopy due to its very low abundance. Unlike other urea cycle proteins, the Nags 233 was more abundant in the livers of mice fed LP diet than in the livers of mice fed HP 234 diet ( Figures 2D and 2E ). changed abundance over time we focused on analyzing differences in protein abundance 240 at T0. Of the 1073 proteins that were identified and quantified in mice fed HP and LP 241 at T0, 335 had fold change ±1.2 or more and p<0.05 ( Figure S3 ). When lists of genes 242 that were differentially expressed were analyzed using Integrated Pathway Analysis 243 software package, there were no obvious signaling or metabolic pathways that responded 244 to dietary protein intake. We then looked simultaneously at ±1.5-fold changes in mRNA 245 and protein abundance in mice fed HP and LP at T0 (Figure 3) . Abundance of mRNA 246 and protein for aldehyde dehydrogenase X (AdhX) and glycine dehydrogenase (Gldh) 247 was higher in mice fed HP, while 11 mRNA and proteins were down regulated in these 248 mice ( Figure 3 and Table S2 ). 70 proteins were at least 1.5-fold more abundant in the 249 livers of mice fed HP while 24 proteins were at least 1.5-fold less abundant, while the 250 abundance of their mRNA did not change ( Figure 3 and Table S2 ). Many of the genes 251 and proteins that were up or down-regulated in mice fed HP participate in metabolism 252 of amino acids, carbohydrates, fats and steroids (Figure 4 ). Defects in many proteins 253 that are up-regulated in mice fed HP cause inborn errors of metabolism. Absence or 254 reduction in activity of PCCA and PCCB cause propionic academia [42] ; maple syrup 255 urine disease is caused by defects in BCKDHA and BCKDHB genes and proteins [43] , 256 metymalonyl academia is caused by defects in the MUT gene and protein [44] .
257
Although mice fed HP and LP had the same fat intake, the acetyl CoA carboxylase α 258 (Accα), fatty acid synthase (Fasn) and 3-hydroxy-3-methyl-glutaryl-coenzyme A 259 reductase (Hmgcr), the key enzymes of the fatty acid and steroid biosynthesis [45] [46] [47] 260 were down regulated in mice fed HP (Figure 4 ). This prompted us to validate mRNA 261 expression changes of these three genes and to examine expression levels of Ampk α 262 mRNA because it regulates activity and expression of the three enzymes [45, 48, 49] . (Thr 37/46 ) in the 4E-BP1, followed by immunoblotting with antibodies that detect the 283 total amount of the three proteins. Beta-actin was used as a loading control ( Figure S4) . 284 Phosphorylation levels of each protein were calculated from the ratio of band intensities 285 of the phosphorylated and total protein and normalized to the β-actin levels. There was 286 a trend (p=0.097) toward different pattern of Thr 172 phosphorylation levels of the 287 Ampkαin mice fed HP and LP. The fasting levels of Thr 172 phosphorylation levels were 288 lower in mice fed HP and they tended to increase thereafter, while phosphorylation of 289 Thr 172 decreased during and after a LP meal ( Figure 6A signaling results in increased expression of the CPS1 and OTC mRNA. Primary human 307 hepatocytes were treated either with AICAR, which activates AMPK, or with AICAR 308 and compound C, a reversible inhibitor of AMPK, or with PBS as a control, followed by 309 measurements of cell viability and the CPS1 and OTC mRNA levels. These treatments 310 did not affect viability of the primary human hepatocytes ( Figure 7A ). Expression levels 311 of CPS1 and OTC mRNA increased 1.8-and 2.8-fold, respectively, in primary human 312 hepatocytes treated with AICAR ( Figures 7B and 7C) . Expression of the CPS1 mRNA 313 decreased two-fold in cells treated with AICAR and compound C, while the expression 314 levels of the OTC mRNA remained unchanged ( Figures 7B and 7C ). These data 
Discussion

318
The goal of this study was to identify signaling pathways that regulate expression of 319 urea cycle genes in response to changes in the dietary protein intake. We used integrated 320 transcriptional and proteomic profiling to show that activation of the AMPK signaling 321 correlates with increased expression of urea cycle genes in mice fed HP diet. A direct 322 role of AMPK in increased expression of at least two urea cycle genes, CPS1 and OTC, 323 was confirmed in human primary hepatocytes treated with AMPK activator AICAR.
324
The decreased abundance of the Nags protein in response to HP diet was unexpected
325
and may indicate a different regulatory mechanism for expression of the mouse Nags L-arginine [50, 51] and intake of this amino acid would be higher in mice fed HP diet.
328
Therefore, it is possible that higher intake of L-arginine in mice fed HP diet activated
329
Nags and resulted in higher production of NAG for activation of CPS1 despite lower regulation of expression of at least two urea cycle genes. Our results are also consistent 347 with the possibility that regulation of urea cycle genes and enzymes was in response to 348 low carbohydrate instead of high protein intake because the fraction of starch was 349 varied in the diets of experimental animals depending on the protein content.
351
The patterns of the AMPK Thr 172 phosphorylation differed in mice fed either HP or LP 352 diet. Because Thr 172 can be phosphorylated by the liver kinase B1 (LKB1), which can 353 be activated by the protein kinase A (PKA) and cAMP [53] , and cAMP and PKA also 354 activate expression of urea cycle genes [19, 20, 22, 24-26, 41, 54] we propose that AMPK 355 could be downstream of cAMP and PKA in the signaling cascade that regulates 356 expression of urea cycle genes in response to diet. intake and adjust expression of urea cycle genes and enzymes accordingly, the low 364 protein diet can put these patients at increased risk of hyperammonemia due to further 365 decrease of their already low capacity to produce urea. A drug treatment targeted at 366 increasing expression of urea cycle genes and enzymes, including the partially defective 367 one, despite a low protein diet, could benefit patients with partial UCD by increasing 368 their capacity to produce urea and decreasing the risk of hyperammonemia. Because of 369 its central role in cellular energy metabolism, AMPK has been implicated in diseases 370 such as diabetes, cancer and obesity, and has been a target for drug development [55] 371 that also might benefit patients with UCD. Figure 2 . Expression of urea cycle genes and enzymes in mice fed either HP (dark gray) or LP (light gray) diets. The mRNA abundance was measured using Affymetrix microarrays (A) and validated with quantitative RT-PCR in a different cohort of mice (B). The abundance of urea cycle enzymes was measured using spike-in mass spectrometry (C) and validated with immunoblotting in a different cohort of mice (D and E). Abundance of mRNA and proteins was measured at fasting and 30, 60 and 120 min. after introduction of food. Each data point is a mean and associated SEM of 4 measurements. 
